Offering patients a choice in CRC screening matters. Cologuard is an effective, noninvasive CRC screening option for patients aged 45 years and older at average risk.1
The Effect of a Shared Decision-Making Process on Acceptance of
Colorectal Cancer Screening2
Study data as published in Annals of Family Medicine in 2022
Is on a Mission to Screen
Katie Couric, award-winning journalist and colorectal cancer screening advocate, is teaming up with Exact Sciences to highlight the urgent need to get patients screened for CRC.
Learn why early detection of CRC is vital
See the Cologuard clinical evidence